Using genetic testing to treat depression and anxiety | A/Prof Kathy Wu

A/Prof Kathy Wu, Head of St Vincent's Clinical Genomics, is leading a new trial focussed on genetics and anti-depressants.
The ENACT Trial uses a simple genetic test (pharmacogenomics) through a cheek swab to help tailor antidepressant treatment to patients. Currently, despite anti-depressants being one of the most common medications in Australia, the process of starting on this medication is based on a trial-and-error approach.
Dr Wu seeks to change this, using this targeted approach to increase the success rate of these medications.
Contents:
00:00 - Introduction
00:14 - The purpose of this trial
1:18 - How is this done?
1:48 - Results so far
Visit our website: www.svhs.org.au/
/ stvincentshospitalsydney
/ stvincentshospitalsydney
/ st-vincents-health-net...